ArticleCritical care explorations2019

Predicted Economic Benefits of a Novel Biomarker for Earlier Sepsis Identification and Treatment: A Counterfactual Analysis.

Carly J Paoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.